MicroRNA Biomarker Market By Product Type (Instruments, Kits & Reagents, Software), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, Northern Blotting, Isothermal Nucleic Acid Amplification Technology (INAAT), Others), By Biomarker Type (Circulating MicroRNAs, Tissue-Derived MicroRNAs, Extracellular Vesicle-Associated miRNAs), By Application (Cancer Diagnosis & Prognosis, Neurological Disorders, Cardiovascular Diseases, Autoimmune Disorders, Infectious Diseases, Other), By End-User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs)), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. MicroRNA Biomarker Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing cancer, cardiovascular, and neurological cases boost demand for miRNA diagnostics

3.2.2. miRNA's role in precision medicine and targeted therapies drives research and adoption

3.2.3. Government and private funding for miRNA-based diagnostics are boosting innovation and commercialization

3.3. Key industry pitfalls & challenges

3.3.1. Advanced techniques like NGS and microarrays are expensive, limiting widespread adoption

3.3.2. Stringent approval processes for miRNA-based diagnostics delay market entry and commercialization

3.3.3. Low awareness among healthcare professionals and limited infrastructure slow market growth

3.4. Market Opportunities

3.4.1. AI-driven tools can enhance biomarker discovery, improving diagnostic accuracy

3.4.2. Pharmaceutical companies explore miRNA biomarkers for therapy response, enhancing collaborations

3.4.3. Expanding research on circulating miRNAs in liquid biopsy could open new avenues in early disease detection

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. MicroRNA Biomarker Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Instruments

4.2.1. Market Size and Forecast, 2025-2035 (USD Million)

4.3. Kits & Reagents

4.3.1. Market Size and Forecast, 2025-2035 (USD Million)

4.4. Software

4.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5. MicroRNA Biomarker Market, Technology Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Technology, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Polymerase Chain Reaction (PCR)

5.2.1. Market Size and Forecast, 2025-2035 (USD Million)

5.3. Next-Generation Sequencing (NGS)

5.3.1. Market Size and Forecast, 2025-2035 (USD Million)

5.4. Microarray Technology

5.4.1. Market Size and Forecast, 2025-2035 (USD Million)

5.5. Northern Blotting

5.5.1. Market Size and Forecast, 2025-2035 (USD Million)

5.6. Isothermal Nucleic Acid Amplification Technology (INAAT)

5.6.1. Market Size and Forecast, 2025-2035 (USD Million)

5.7. Others

5.7.1. Market Size and Forecast, 2025-2035 (USD Million)

6. MicroRNA Biomarker Market, Biomarker Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Biomarker Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Circulating MicroRNAs

6.2.1. Market Size and Forecast, By 2025-2035(USD Million)

6.3. Tissue-Derived MicroRNAs

6.3.1. Market Size and Forecast, By 2025-2035(USD Million)

6.4. Extracellular Vesicle-Associated miRNAs

6.4.1. Market Size and Forecast, By 2025-2035(USD Million)

7. MicroRNA Biomarker Market, Application Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Application, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Cancer Diagnosis & Prognosis

7.2.1. Market Size and Forecast, 2025-2035 (USD Million)

7.3. Neurological Disorders

7.3.1. Market Size and Forecast, 2025-2035 (USD Million)

7.4. Cardiovascular Diseases

7.4.1. Market Size and Forecast, 2025-2035 (USD Million)

7.5. Autoimmune Disorders

7.5.1. Market Size and Forecast, 2025-2035 (USD Million)

7.6. Infectious Diseases

7.6.1. Market Size and Forecast, 2025-2035 (USD Million)

7.7. Other

7.7.1. Market Size and Forecast, 2025-2035 (USD Million)

8. MicroRNA Biomarker Market, End-User Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-User, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals & Diagnostic Laboratories

8.2.1. Market Size and Forecast, 2025-2035 (USD Million)

8.3. Pharmaceutical & Biotechnology Companies

8.3.1. Market Size and Forecast, 2025-2035 (USD Million)

8.4. Academic & Research Institutes

8.4.1. Market Size and Forecast, 2025-2035 (USD Million)

8.5. Contract Research Organizations (CROs)

8.5.1. Market Size and Forecast, 2025-2035 (USD Million)

9. MicroRNA Biomarker Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Million)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Million)

9.2.2. North America Market Revenue, By Product Type, 2025-2035

9.2.3. North America Market Revenue, By Technology, 2025-2035

9.2.4. North America Market Revenue, By Biomarker Type, 2025-2035

9.2.5. North America Market Revenue, By Application, 2025-2035

9.2.6. North America Market Revenue, By End-User, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Product Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.3. U.S. Market Revenue, By Biomarker Type, 2025-2035

9.2.7.4. U.S. Market Revenue, By Application, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-User, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Product Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Technology, 2025-2035

9.2.8.3. Canada Market Revenue, By Biomarker Type, 2025-2035

9.2.8.4. Canada Market Revenue, By Application, 2025-2035

9.2.8.5. Canada Market Revenue, By End-User, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Million)

9.3.2. Europe Market Revenue, By Product Type, 2025-2035

9.3.3. Europe Market Revenue, By Technology, 2025-2035

9.3.4. Europe Market Revenue, By Biomarker Type, 2025-2035

9.3.5. Europe Market Revenue, By Application, 2025-2035

9.3.6. Europe Market Revenue, By End-User, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Product Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Technology, 2025-2035

9.3.7.3. Germany Market Revenue, By Biomarker Type, 2025-2035

9.3.7.4. Germany Market Revenue, By Application, 2025-2035

9.3.7.5. Germany Market Revenue, By End-User, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Product Type, 2025-2035

9.3.8.2. France Market Revenue, By Technology, 2025-2035

9.3.8.3. France Market Revenue, By Biomarker Type, 2025-2035

9.3.8.4. France Market Revenue, By Application, 2025-2035

9.3.8.5. France Market Revenue, By End-User, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Product Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.3. U.K. Market Revenue, By Biomarker Type, 2025-2035

9.3.9.4. U.K. Market Revenue, By Application, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-User, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Product Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Technology, 2025-2035

9.3.10.3. Italy Market Revenue, By Biomarker Type, 2025-2035

9.3.10.4. Italy Market Revenue, By Application, 2025-2035

9.3.10.5. Italy Market Revenue, By End-User, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Product Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Technology, 2025-2035

9.3.11.3. Spain Market Revenue, By Biomarker Type, 2025-2035

9.3.11.4. Spain Market Revenue, By Application, 2025-2035

9.3.11.5. Spain Market Revenue, By End-User, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Biomarker Type, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Application, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-User, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Million)

9.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Biomarker Type, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Application, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-User, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Product Type, 2025-2035

9.4.7.2. China Market Revenue, By Technology, 2025-2035

9.4.7.3. China Market Revenue, By Biomarker Type, 2025-2035

9.4.7.4. China Market Revenue, By Application, 2025-2035

9.4.7.5. China Market Revenue, By End-User, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Product Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Technology, 2025-2035

9.4.8.3. Japan Market Revenue, By Biomarker Type, 2025-2035

9.4.8.4. Japan Market Revenue, By Application, 2025-2035

9.4.8.5. Japan Market Revenue, By End-User, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Product Type, 2025-2035

9.4.9.2. India Market Revenue, By Technology, 2025-2035

9.4.9.3. India Market Revenue, By Biomarker Type, 2025-2035

9.4.9.4. India Market Revenue, By Application, 2025-2035

9.4.9.5. India Market Revenue, By End-User, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Product Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Technology, 2025-2035

9.4.10.3. Australia Market Revenue, By Biomarker Type, 2025-2035

9.4.10.4. Australia Market Revenue, By Application, 2025-2035

9.4.10.5. Australia Market Revenue, By End-User, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Product Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.3. South Korea Market Revenue, By Biomarker Type, 2025-2035

9.4.11.4. South Korea Market Revenue, By Application, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-User, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Product Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.3. Singapore Market Revenue, By Biomarker Type, 2025-2035

9.4.12.4. Singapore Market Revenue, By Application, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-User, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Biomarker Type, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-User, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Million)

9.5.2. Latin America Market Revenue, By Product Type, 2025-2035

9.5.3. Latin America Market Revenue, By Technology, 2025-2035

9.5.4. Latin America Market Revenue, By Biomarker Type, 2025-2035

9.5.5. Latin America Market Revenue, By Application, 2025-2035

9.5.6. Latin America Market Revenue, By End-User, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.3. Brazil Market Revenue, By Biomarker Type, 2025-2035

9.5.7.4. Brazil Market Revenue, By Application, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-User, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.3. Argentina Market Revenue, By Biomarker Type, 2025-2035

9.5.8.4. Argentina Market Revenue, By Application, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-User, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.3. Mexico Market Revenue, By Biomarker Type, 2025-2035

9.5.9.4. Mexico Market Revenue, By Application, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-User, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Technology, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Biomarker Type, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Application, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-User, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Million)

9.6.2. MEA Market Revenue, By Product Type, 2025-2035

9.6.3. MEA Market Revenue, By Technology, 2025-2035

9.6.4. MEA Market Revenue, By Biomarker Type, 2025-2035

9.6.5. MEA Market Revenue, By Application, 2025-2035

9.6.6. MEA Market Revenue, By End-User, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Product Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Biomarker Type, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Application, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-User, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Product Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.3. South Africa Market Revenue, By Biomarker Type, 2025-2035

9.6.8.4. South Africa Market Revenue, By Application, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-User, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Biomarker Type, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-User, 2025-2035

10. Company Profile

10.1. Thermo Fisher Scientific, Inc.

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Illumina, Inc.

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. QIAGEN

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Merck KGaA

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Bio-Rad Laboratories, Inc.

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. PerkinElmer

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Takara Bio Inc.

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Revvity Discovery Limited

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. BioGenex

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. GeneCopoeia, Inc.

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Bruker Spatial Biology, Inc.

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Quantabio

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. SeqMatic LLC

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. OriGene Technologies, Inc.

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Phalanx Biotech Group

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis